Cushing's Syndrome and the Markers of Cortisol Excess
Cushing’s Syndrome biomarkers are the body’s chemical fingerprints of chronic cortisol overload and the signals that drive it. The centerpiece is cortisol (hydrocortisone), made by the adrenal cortex, which mobilizes fuel, supports blood pressure, and tempers immune activity; in Cushing’s it stays inappropriately high and loses its normal day-night rhythm across the day. Its upstream controller is ACTH (adrenocorticotropic hormone) from the pituitary, which tells the adrenals how much cortisol to make; interpreting ACTH alongside cortisol shows whether the system is being pushed from above or from the adrenal itself. Related adrenal steroids and cortisol’s downstream footprints on metabolism and salt balance (androgen precursors, glucose handling, and potassium regulation) add corroborating signals about how far cortisol’s effects have spread. Taken together, these measurements provide a functional snapshot of the HPA axis (hypothalamic-pituitary-adrenal axis): they confirm sustained cortisol exposure, reveal disruption of normal hormonal rhythm, gauge impact on tissues, and point clinicians toward the likely source of excess hormone to guide next diagnostic steps and treatment.
Why Cortisol Patterns Matter More Than a Single Number
Cushing’s syndrome blood biomarkers reveal how the stress-hormone axis is behaving across the whole body. Cortisol is the executive signal of the hypothalamic–pituitary–adrenal (HPA) system; when persistently high, it drives central weight gain, high blood pressure and glucose, bone loss, skin/muscle thinning, immune suppression, and mood/cognitive change. DHEAS, an adrenal androgen, helps point to an adrenal source when elevated alongside cortisol and provides context for sex- and age-specific effects.Cortisol normally peaks in the early morning and is lowest near midnight; healthy results sit in the middle of the time‑of‑day range. DHEAS sits midrange for age and sex, peaking in young adulthood and declining with age. In Cushing’s, cortisol is inappropriately high and often loses its late‑night low point; DHEAS may be high if the adrenal gland is the driver. This can bring acne, oily skin, and hirsutism in women, reduced fertility in both sexes, and growth deceleration with weight gain in children and teens. Pregnancy alters binding proteins and daily rhythm, so interpretation must account for gestational physiology.When values are low, Cushing’s becomes unlikely and adrenal suppression or insufficiency is considered. Low cortisol brings fatigue, weight loss, low blood pressure, salt craving, and hypoglycemia; low DHEAS can reflect pituitary–adrenal suppression or aging and may relate to low libido and dry skin, especially in women.Big picture, these tests map HPA-axis tone that intersects with metabolism, cardiovascular risk, bone integrity, infection resilience, mood, and long‑term mortality. Getting the cortisol–DHEAS story right clarifies cause, gauges severity, and frames the downstream risks that matter over years.
What Cortisol Testing Can and Can't Settle
Cushing’s Syndrome blood testing is essential for understanding how your body manages stress, energy, and metabolism at a systems level. This syndrome results from prolonged exposure to high levels of cortisol, a hormone that affects nearly every organ system—including cardiovascular health, immune function, cognition, and reproductive balance. At Superpower, we focus on two key biomarkers: Cortisol and DHEAS.Cortisol is the primary stress hormone produced by the adrenal glands. It helps regulate blood sugar, blood pressure, and the body’s response to stress. In Cushing’s Syndrome, cortisol levels are abnormally high, which can disrupt normal metabolic processes and lead to symptoms like weight gain, muscle weakness, and high blood pressure. DHEAS (dehydroepiandrosterone sulfate) is another hormone made by the adrenal glands. It serves as a counterbalance to cortisol and is involved in the production of sex hormones. In Cushing’s Syndrome, DHEAS levels may be low, normal, or sometimes elevated, depending on the underlying cause.Healthy cortisol and DHEAS levels are crucial for maintaining stability across multiple body systems. When cortisol is persistently elevated, it can impair immune defense, weaken bones, and disturb mood and memory. DHEAS helps support resilience and hormonal balance, so changes in its levels can signal shifts in adrenal function and overall system health.Interpretation of these biomarkers depends on several factors. Age, pregnancy, acute illness, and certain medications (like steroids or oral contraceptives) can all influence cortisol and DHEAS levels. Laboratory methods and timing of sample collection also affect results, so context is key for accurate assessment.
FAQs
It checks whether your body is making too much cortisol over time. Superpower tests your blood for Cortisol and DHEA-S. Cortisol reflects your stress hormone output; DHEA-S reflects adrenal androgen activity and ACTH drive. Together they show how your hypothalamic–pituitary–adrenal axis and adrenal cortex are behaving. Blood tests help screen and stage suspicion; confirmation often requires timed or suppression tests to prove persistent hypercortisolism.
If you have features of cortisol excess—central weight gain, thin skin and bruising, muscle weakness, high blood pressure or glucose, bone loss, mood or sleep changes—testing clarifies whether your cortisol regulation is chronically dysregulated. Identifying hypercortisolism early protects cardiovascular, metabolic, bone, and immune systems. It also helps separate true Cushing’s Syndrome from common look‑alikes like chronic stress states or medication effects.
Yes. With Superpower, our team member can organize a professional blood draw in your home. Timing matters for cortisol’s daily rhythm, so we schedule appropriately to capture morning levels or other required time points. The process is quick, temperature‑controlled, and lab‑tracked end to end.
For screening, a single timed set is typical. If results are abnormal or borderline, repeat measurements and confirmatory tests are used to document persistent hypercortisolism. During treatment or remission surveillance, intervals vary by clinical course—often every 3–12 months—to track recurrence risk and system recovery in blood pressure, glucose, and bone metabolism.
Cortisol follows a circadian rhythm and spikes with acute stress, pain, illness, sleep loss, or shift work. Estrogen therapy and pregnancy raise cortisol‑binding globulin and total cortisol. Glucocorticoids suppress cortisol; enzyme‑inducing drugs can lower levels. Alcohol use, severe depression, obesity, and chronic illness can elevate or blur patterns. DHEA-S declines with age and reflects ACTH drive; kidney or liver disease can alter measured values.
Plan a morning draw (around 7–10 AM) unless otherwise specified. Avoid strenuous exercise and heavy alcohol the day before. Do not stop prescribed medicines unless you were told to; tell us about steroid use and estrogen‑containing therapies because they affect results. Fasting is usually not required. Rest quietly for 10–15 minutes before the draw to reduce stress‑related cortisol spikes.
References
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008). The diagnosis of Cushing's syndrome: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1526-1540. https://doi.org/10.1210/jc.2008-0125
- Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015). Cushing's syndrome. The Lancet, 386(9996), 913-927. https://doi.org/10.1016/S0140-6736(14)61375-1
- Hong, A. R., Kim, J. H., Hong, E. S., Kim, I. K., Park, K. S., Ahn, C. H., Kim, S. W., Shin, C. S., & Kim, S. Y. (2015). Limited diagnostic utility of plasma adrenocorticotropic hormone for differentiation between adrenal Cushing syndrome and Cushing disease. Endocrinology and Metabolism, 30(3), 297-304. https://doi.org/10.3803/EnM.2015.30.3.297
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015). Treatment of Cushing's syndrome: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(8), 2807-2831. https://doi.org/10.1210/jc.2015-1818
- Dupuis, H., Merlen, E., Elices-Diez, J., Balayé, P., Cortet, C., Jannin, A., Do Cao, C., Douillard, C., Soulez, B., Ramdane, N., Soudan, B., Vantyghem, M. C., & Espiard, S. (2025). Performance of afternoon (16:00 h) serum cortisol for the diagnosis of Cushing's syndrome. Clinical Chemistry and Laboratory Medicine, 63(11), 2254-2263. https://doi.org/10.1515/cclm-2025-0133






































.avif)
